Yes, artificial intelligence (AI)-assisted colonoscopy has been shown to improve adenoma detection rates (ADR). Adenoma detection is a critical measure in colonoscopy, as higher ADRs are directly linked to reduced colorectal cancer (CRC) incidence and mortality.
Yes, artificial intelligence (AI)-assisted colonoscopy has been shown to improve adenoma detection rates (ADR). Adenoma detection is a critical measure in colonoscopy, as higher ADRs are directly linked to reduced colorectal cancer (CRC) incidence and mortality. Despite advancements, up to 20% of adenomas are still missed due to human limitations in visual detection.
A study conducted at Hallym University Dongtan Sacred Heart Hospital evaluated AI-assisted colonoscopy using the SmartEndo CADe system, a deep-learning tool that highlights potential polyps in real time through bounding boxes and auditory alerts. The study included 474 patients in the AI-assisted group and compared them with 474 patients undergoing standard colonoscopy. Propensity score matching ensured both groups were balanced for clinical and procedural characteristics.
The AI-assisted colonoscopy significantly improved ADR (35.9% vs. 26.4%, p=0.002), demonstrating its effectiveness in routine practice. It also increased the polyp detection rate (53.2% vs. 46.2%, p=0.038) and the mean adenomas per colonoscopy (0.69 vs. 0.43, p<0.001). AI systems were particularly beneficial for trainees, boosting their ADR from 27.2% to 51.5% (p=0.023). Additionally, AI-assisted colonoscopy proved valuable in detecting subtle, small, or flat lesions, even among high-performing endoscopists.
While AI improves detection, challenges such as false positives and increased procedure time persist. However, AI assistance standardizes detection quality, reduces operator variability, and enhances early CRC prevention. Despite limitations like the study’s retrospective nature, AI-assisted colonoscopy represents a significant advancement in improving colonoscopy quality and outcomes.
Introduction: Artificial intelligence is rapidly transforming healthcare through drug discovery, clinical decision support, remote monitoring, and administrative automation. While AI is widely expected to reduce healthcare costs, this perspective argues that current payment models and...
Introduction: Large frontier AI models such as GPT-5 and Gemini have achieved impressive results across numerous healthcare benchmarks. However, high benchmark scores alone may not reflect real-world clinical reliability. This study systematically evaluated the robustness...
Introduction: Artificial intelligence is rapidly transforming medicine, but its influence extends far beyond healthcare. This JAMA AI Conversations article explores how AI ethics has become a global societal issue, engaging technology leaders, policymakers, healthcare professionals,...
Introduction: Artificial intelligence is rapidly transforming oncology, evolving from image interpretation and pathology analysis to supporting complex clinical decision-making. This perspective argues that AI should enhance the capabilities of oncologists rather than replace their expertise....
Introduction Clinical trial endpoints have traditionally relied on expert human interpretation, particularly for pathology-based outcomes. However, variability between observers, cost, and time remain important limitations. This NEJM AI perspective discusses how artificial intelligence is beginning...
Introduction: As artificial intelligence becomes increasingly integrated into clinical practice, an important question arises: should AI assistants be regulated as medical devices or viewed as evidence-based clinical methodologies? This NEJM AI perspective proposes a new...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.